Sg3 Management, LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $573,100 - $1.34 Million	-110,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $56,518 - $132,132	-7,700 Reduced 6.54%	110,000 $1.12 Million
Q4 2021 Feb 15, 2022	BUY	$11.38 - $53.41 $1.34 Million - $6.29 Million	117,700 New	117,700 $1.96 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $468,700 - $642,400	-10,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $464,700 - $639,300	10,000 New	10,000 $610,000
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $2.08 Million - $2.71 Million	-37,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $1.44 Million - $2.67 Million	37,500 New	37,500 $2.67 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.